Evidence map›Paper›PMID 42870827›Full record

ArticleTranslational cancer research2026

Expression, prognostic association, and immune microenvironment correlates of

Sihang Lin, Lixia Liu, Jiayu Guan, Jie Wang, Chuanrong Cen, La Wei, Huawei Yang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Translational cancer research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sihang LinDepartment of Breast Surgery, Key Laboratory of Breast Cancer Diagnosis and Treatment Research of Guangxi Department of Education, Guangxi Medical University Cancer Hospital, Nanning, China.ORCID https://orcid.org/0009-0001-3054-5568
Lixia LiuDepartment of Breast Surgery, Key Laboratory of Breast Cancer Diagnosis and Treatment Research of Guangxi Department of Education, Guangxi Medical University Cancer Hospital, Nanning, China.ORCID https://orcid.org/0009-0002-9730-1098
Jiayu GuanThe Second Clinical Medical College of Jinan University, Shenzhen, China.
Jie WangDepartment of Breast Surgery, Key Laboratory of Breast Cancer Diagnosis and Treatment Research of Guangxi Department of Education, Guangxi Medical University Cancer Hospital, Nanning, China.
Chuanrong CenDepartment of Breast Surgery, Key Laboratory of Breast Cancer Diagnosis and Treatment Research of Guangxi Department of Education, Guangxi Medical University Cancer Hospital, Nanning, China.
La WeiCollege of Stomatology, Hospital of Stomatology, Guangxi Medical University, Nanning, China.
Huawei YangDepartment of Breast Surgery, Key Laboratory of Breast Cancer Diagnosis and Treatment Research of Guangxi Department of Education, Guangxi Medical University Cancer Hospital, Nanning, China.ORCID https://orcid.org/0009-0006-7377-2054

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Chromosome 4 open reading frame 50 ( Methods: RNA-sequencing and clinical data from The Cancer Genome Atlas Breast Invasive Carcinoma (TCGA-BRCA) cohort were analyzed. Results: Conclusions:

Indexed as

breast cancerChromosome 4 open reading frame 50 (C4orf50)prognosistumor microenvironment (TME)tumor purity

Identifiers

PMID42870827
PMCPMC13657826

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.